FDANews
www.fdanews.com/articles/87634-jubilant-may-unveil-a-bid-of-usd-500-mn-for-cambrex

JUBILANT MAY UNVEIL A BID OF USD 500 MN FOR CAMBREX

June 16, 2006

Jubilant Organosys seems to have identified the New Jersey based NYSE-listed life-sciences company, Cambrex, as one of its potential acquisition targets, as it looks for big buys in the US and Europe. The domestic integrated pharma player could unveil a bid with valuation more than USD 500 mn following a due diligence in the next 3-6 months.
Myiris